- Home
- DNTH vs JAMF Comparison
DNTH vs JAMF Comparison
Compare DNTH & JAMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- JAMF
- Stock Information
- Founded
- DNTH 2015
- JAMF 2002
- Country
- DNTH United States
- JAMF United States
- Employees
- DNTH N/A
- JAMF N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- JAMF Computer Software: Prepackaged Software
- Sector
- DNTH Health Care
- JAMF Technology
- Exchange
- DNTH Nasdaq
- JAMF Nasdaq
- Market Cap
- DNTH 1.5B
- JAMF 1.4B
- IPO Year
- DNTH N/A
- JAMF 2020
- Fundamental
- Price
- DNTH $36.05
- JAMF $10.00
- Analyst Decision
- DNTH Strong Buy
- JAMF Buy
- Analyst Count
- DNTH 11
- JAMF 11
- Target Price
- DNTH $65.22
- JAMF $16.27
- AVG Volume (30 Days)
- DNTH 664.6K
- JAMF 1.8M
- Earning Date
- DNTH 11-06-2025
- JAMF 11-06-2025
- Dividend Yield
- DNTH N/A
- JAMF N/A
- EPS Growth
- DNTH N/A
- JAMF N/A
- EPS
- DNTH N/A
- JAMF N/A
- Revenue
- DNTH $4,854,000.00
- JAMF $666,382,000.00
- Revenue This Year
- DNTH N/A
- JAMF $14.24
- Revenue Next Year
- DNTH N/A
- JAMF $9.60
- P/E Ratio
- DNTH N/A
- JAMF N/A
- Revenue Growth
- DNTH 17.87
- JAMF 11.36
- 52 Week Low
- DNTH $13.37
- JAMF $7.09
- 52 Week High
- DNTH $40.16
- JAMF $18.00
- Technical
- Relative Strength Index (RSI)
- DNTH 57.06
- JAMF 47.39
- Support Level
- DNTH $33.34
- JAMF $10.06
- Resistance Level
- DNTH $36.68
- JAMF $10.34
- Average True Range (ATR)
- DNTH 2.11
- JAMF 0.39
- MACD
- DNTH -0.53
- JAMF -0.16
- Stochastic Oscillator
- DNTH 39.74
- JAMF 17.87
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About JAMF Jamf Holding Corp.
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.